Regulation of Btk by Src family tyrosine kinases

Molecular and Cellular Biology

Volumn 16, Issue 7, 1996, Pages 3465-3471

  Afar, Daniel E H ^a   Park, Hyunsun ^a   Howell, Brian W ^b   Rawlings, David J ^a   Cooper, Jonathan ^b   Witte, Owen N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; INTERLEUKIN 5; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REGULATION; FIBROBLAST; IMMUNE DEFICIENCY; IMMUNOBLOTTING; MOUSE; MUTANT; NONHUMAN; PEPTIDE MAPPING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT;

EID: 0029891789     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.7.3465     Document Type: Article

References (54)

1. Alexandropoulos, K., G. Cheng, and D. Baltimore. 1995. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc. Natl. Acad. Sci. USA 92:3110-3114.
2. Aoki, Y., K. J. Isselbacher, and S. Pillai. 1994. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc Natl. Acad. Sci. USA 91:10606-10609.
3. Bolen, J. B. 1995. Protein tyrosine kinases in the initiation of antigen receptor signaling. Curr. Opin. Immunol. 7:306-311.
4. Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
5. Broume, M. A., and T. Hunter. The PDGF receptor phosphorylates Tyr138 in the c-src SH3 domain in vivo reducing peptide ligand binding. J. Biol. Chem., in press.
6. Calalb, M. B., T. R. Polte, and S. K. Hanks. 1995. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15:954-963.
7. Cheng, G., Z.-S. Ye, and D. Baltimore. 1994. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc. Natl. Acad. Sci. USA 91:8152-8155.
8. csk. Nature (London) 365:156-160.
9. Chow, L. M. L., and A. Veillette. 1995. The Src and Csk families of tyrosine kinases in hematopoietic cells. Semin. Immunol. 7:207-226.
10. Cooper, J. A., and B. Howell. 1993. The when and how of src regulation. Cell 63:1051-1054.
11. Cory, G. O. C., R. C. Levering, S. Hinshelwood, L. MacCarthy-Morrogh, R. J. Levinsky, and C. Kinnon. 1995. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J. Exp. Med. 182:611-615.
12. de Weers, M., G. S. Brouns, S. Hinshelwood, C. Kinnon, R. K. B. Schuurman, R. W. Hendriks, and J. Borst. 1994. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J. Biol. Chem. 269:23857-23860.
13. Franz, W. M., P. Berger, and J. Y. J. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137-147.
14. Grant, S. G. N., K. A. Karl, M. A. Kiebler, and E. R. Kandel. 1995. Focal adhesion kinase in the brain: novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice. Genes Dev. 9:1901-1921.
15. Hanks, S. K., A. M. Quinn, and T. Hunter. 1988 The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42-52.
16. Howell, B. W., and J. A. Cooper. 1994. Csk suppression of Src involves movement of Csk to sites of Src activity. Mol. Cell. Biol. 14:5402-5411.
17. 16a.Howell, B. W., and J. A. Cooper. Unpublished observation.
18. Imamoto, A., and P. Soriano. 1993. Disruption of the csk gene, encoding a negative regulator of src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73:1117-1124.
19. Jackson, P., and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8:449-456.
20. Kawakami, Y., L. Yao, T. Miura, S. Tsukada, O. N. Witte, and T. Kawakami. 1994. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon FcεRI cross-linking. Mol. Cell. Biol. 14:5108-5113.
21. Kurosaki, T., M. Takata, Y. Yamanashi, T. Inazu, T. Taniguchi, T. Yamamoto, and H. Yamamura. 1994. Syk activation by the src-family tyrosine kinase in the B cell receptor signaling. J. Exp. Med. 179:1725-1729.
22. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (London) 304:596-602.
23. + gene product overexpressed in chicken embryo fibroblasts. Mol. Cell. Biol. 9:3332-3341.
24. c-src by a single amino acid change. Proc. Natl. Acad. Sci. USA 83:4228-4232.
25. 23a.Li, J., and O. N. Witte. Unpublished data.
26. Li, T., S. Tsukada, A. Satterthwaite, M. H. Havlik, H. Park, K. Takatsu, and O. N. Witte. 1995. Activation of Bruton's tyrosine kinase (Btk) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2:451-460.
27. Lipsich, L. A., A. J. Lewis, and J. S. Brugge. 1983. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J. Virol. 48:352-360.
28. Lugo, T. G., and O. N. Witte. 1989. The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol. Cell. Biol. 9:1263-1270.
29. Mahajan, S., J. Fargnoli, A. L. Burkhardt, S. A. Kut, S. J. Saouaf, and J. B. Bolen. 1995. Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. Mol. Cell. Biol. 15:5304-5311.
30. Matsuda, T., M. Takahashi-Tezuka, T. Fukada, Y. Okuyama, Y. Fujitani, S. Tsukada, H. Mano, H. Hirai, O. N. Witte, and T. Hirano. 1995. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the IL-6 family of cytokines. Blood 85:627-633.
31. Mayer, B. J., M. Hamaguchi, and H. Hanafusa. 1988. A novel viral oncogene with structural similarity to phospholipasc C. Nature (London) 332:272-275.
32. Miller, A. D., D. G. Miller, J. V. Garcia, and C. M. Lynch. 1993. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217:581-599.
33. Muller, A. J., J. C. Young, A.-M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785-1792.
34. Murphy, S. M., M. Bergman, and D. O. Morgan. 1993. Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae. Mol. Cell. Biol. 13:5290-5300.
35. c-src. Nature (London) 351:69-72.
36. Nada, S., T. Vagi, H. Takeda, T. Tokunaga, H. Nakagawa, Y. Ikawa, M. Okada, and S. Aizawa. 1993. Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell 73:1125-1135.
37. Noble, M. E. M., A. Musacchio, M. Saraste, S. A. Courtneidge, and R. K. Wierenga. 1993. Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin. EMBO J. 12:2617-2624.
38. Okada, M., B. W. Howell, M. A. Broome, and J. A. Cooper. 1993. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine. J. Biol. Chem. 268:18070-18075.
39. Okada, M., S. Nada, Y. Yamanashi, T. Yamamoto, and H. Nakagawa. 1991. CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J. Biol. Chem. 266:24249-24252.
40. Park, H., M. I. Wahl, D. E. H. Afar, C. W. Turck, D. Rawlings, C. Tam, A. M. Scharenberg, J.-P. Kinet, and O. N. Witte. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity, in press.
41. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
42. Rawlings, D. J., D. C. Saffran, S. Tsukada, D. A. Largaespada, J. C. Grimaldi, L. Cohen, R. N. Mohr, J. F. Bazan, M. Howard, N. G. Copeland, N. A. Jenkins, and O. N. Witte. 1993. Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358-361.
43. Rawlings, D. J., A. M. Scharenberg, H. Park, M. I. Wahl, S. Lin, R. M. Kato, A. C. Fluckiger, O. N. Witte, and J.-P. Kinet. 1996. Activation of Btk by a phosphorylation mechanism initiated by Src family kinases. Science 271:822-825.
44. Rawlings, D. J., and O. N. Witte. 1995. The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation, and function. Semin. Immunol. 7:237-246.
45. Sabe, H., M. Okada, H. Nakagawa, and H. Hanafusa. 1992. Activation of c-Src in cells bearing v-Crk and its suppression by Csk. Mol. Cell. Biol. 12:4706-4713.
46. Saouaf, S. J., S. Mahajan, R. B. Rowley, S. Kut, J. Fargnoli, A. L. Burkhardt, S. Tsukada, O. N. Witte, and J. B. Bolen. 1994. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinase following B cell antigen receptor surface engagement. Proc. Natl. Acad. Sci. USA 91:9524-9528.
47. Sato, S., T. Katagiri, S. Takaki, Y. Kikuchi, Y. Hitoshi, S. Yonehara, S. Tsukada, D. Kitamura, T. Watanabe, O. Witte, and K. Takatsu. 1994. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Btk and JAK2 kinases. J. Exp. Med. 180:2101-2111.
48. Seidel-Dugan, C., B. E. Meyer, S. M. Thomas, and J. S. Brugge. 1992. Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol. 12:1835-1845.
49. Superti-Furga, G., S. Fumagalli, M. Koegl, S. A. Courtneidge, and G. Draetta. 1993. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 12:2625-2634.
50. Thomas, J. D., P. Sideras, C. I. E. Smith, I. Vorechovsky, V. Chapman, and W. E. Paul. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355-358.
51. Tsukada, S., D. C. Saffran, D. J. Rawlings, O. Parolini, R. C. Allen, I. Klisak, R. S. Sparkes, H. Kubagawa, T. Mohandas, S. Quan, J. W. Belmont, M. D. Cooper, M. E. Conley, and O. N. Witte. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279-290.
52. Vetrie, D., I. Vorechovsky, P. Sideras, J. Holland, A. Davies, F. Flinter, L. Hammarström, C. Kinnon, R. Levinsky, M. Bobrow, C. I. E. Smith, and D. R. Bentley. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature (London) 361:226-233.
53. Yang, W., S. N. Malek, and S. Desiderio. 1995. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. J. Biol. Chem. 270:20832-20840.
54. Yoon, C. H., J. Lee, G. D. Jongeward, and P. W. Sternberg. 1995. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-B1. Science 269:1102-1105.